Tami Hood

1.8k total citations
6 papers, 672 citations indexed

About

Tami Hood is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tami Hood has authored 6 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tami Hood's work include Cancer-related gene regulation (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Tami Hood is often cited by papers focused on Cancer-related gene regulation (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Tami Hood collaborates with scholars based in United States and Switzerland. Tami Hood's co-authors include X. Sunney Xie, Paul W. Manley, Andrew A. Wylie, Dan Fu, Jing Zhou, Yan Wang, Nanxin Li, Fangxian Sun, Sung Joon Kim and Gang Xia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Nature Chemistry.

In The Last Decade

Tami Hood

6 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tami Hood United States	5	363	189	151	130	82	6	672
L Villeneuve Canada	12	262 0.7×	91 0.5×	68 0.5×	99 0.8×	14 0.2×	16	584
Carsten Höltke Germany	19	346 1.0×	340 1.8×	51 0.3×	92 0.7×	12 0.1×	53	1.1k
Joe T. Sharick United States	10	575 1.6×	186 1.0×	321 2.1×	93 0.7×	13 0.2×	15	1.3k
Maria M. Lukina Russia	19	359 1.0×	101 0.5×	194 1.3×	108 0.8×	6 0.1×	54	878
He N. Xu United States	19	411 1.1×	74 0.4×	160 1.1×	200 1.5×	10 0.1×	74	938
Birgitte Brinkmann Olsen Denmark	20	691 1.9×	291 1.5×	9 0.1×	115 0.9×	26 0.3×	53	1.1k
Adrian Pasculescu Canada	14	951 2.6×	164 0.9×	26 0.2×	37 0.3×	15 0.2×	23	1.2k
Janine Papon France	20	491 1.4×	222 1.2×	29 0.2×	109 0.8×	7 0.1×	46	954
Gianpaolo Fogliatto Italy	7	518 1.4×	128 0.7×	20 0.1×	81 0.6×	52 0.6×	9	761
Zengliu Su United States	17	964 2.7×	206 1.1×	51 0.3×	168 1.3×	32 0.4×	23	1.3k

Countries citing papers authored by Tami Hood

Since Specialization

Citations

This map shows the geographic impact of Tami Hood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tami Hood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tami Hood more than expected).

Fields of papers citing papers by Tami Hood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tami Hood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tami Hood. The network helps show where Tami Hood may publish in the future.

Co-authorship network of co-authors of Tami Hood

This figure shows the co-authorship network connecting the top 25 collaborators of Tami Hood. A scholar is included among the top collaborators of Tami Hood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tami Hood. Tami Hood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hood, Tami, et al.. (2018). Abstract 808: Opportunity for therapeutic expansion in mantle cell lymphoma: Tazemetostat combination synergy status in preclinical MCL models. Cancer Research. 78(13_Supplement). 808–808. 2 indexed citations

2.

Michellys, Pierre‐Yves, Bei Chen, Tao Jiang, et al.. (2015). Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(3). 1090–1096. 11 indexed citations

3.

Fu, Dan, Jing Zhou, Paul W. Manley, et al.. (2014). Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering. Nature Chemistry. 6(7). 614–622. 231 indexed citations

4.

Fan, Yi, Yuan Mi, Fangxian Sun, et al.. (2012). Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. ACS Medicinal Chemistry Letters. 3(2). 140–145. 81 indexed citations

5.

Shultz, Michael D., C.A. Kirby, Travis Stams, et al.. (2012). [1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt Pathway That Inhibit Tankyrases 1 and 2 via Novel Adenosine Pocket Binding. Journal of Medicinal Chemistry. 55(3). 1127–1136. 58 indexed citations

6.

Galkin, Anna, Sung Joon Kim, Tami Hood, et al.. (2006). Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proceedings of the National Academy of Sciences. 104(1). 270–275. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact